Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity

Romana Wass; Maximilian J. Hochmair; Bernhard Kaiser; Brane Grambozov; Felix Sedlmayer; Bernd Lamprecht; Michael Studnicka; Franz Zehentmayr

doi:10.3390/cancers14133226

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity

Romana Wass, Maximilian J. Hochmair, Bernhard Kaiser, Brane Grambozov, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr

Department of Internal Medicine 4 - Pneumology and Infectious Diseases

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	3226
Number of pages	13
Journal	Cancers
Volume	14
Issue number	13
DOIs	https://doi.org/10.3390/cancers14133226
Publication status	Published - May 2022

Fields of science

302030 Internal medicine
302068 Pulmology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/cancers14133226

Cite this

@article{647b0bcb7dd24cc198415e3feb519d4e,

title = "Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity",

author = "Romana Wass and Hochmair, {Maximilian J.} and Bernhard Kaiser and Brane Grambozov and Felix Sedlmayer and Bernd Lamprecht and Michael Studnicka and Franz Zehentmayr",

year = "2022",

month = may,

doi = "10.3390/cancers14133226",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI",

number = "13",

}

TY - JOUR

T1 - Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity

AU - Wass, Romana

AU - Hochmair, Maximilian J.

AU - Kaiser, Bernhard

AU - Grambozov, Brane

AU - Sedlmayer, Felix

AU - Lamprecht, Bernd

AU - Studnicka, Michael

AU - Zehentmayr, Franz

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85133128088&partnerID=8YFLogxK

U2 - 10.3390/cancers14133226

DO - 10.3390/cancers14133226

M3 - Article

C2 - 35804997

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 13

M1 - 3226

ER -

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this